Obstet Gynecol. 2021 Jul 1;138(1):e1-e15. doi: 10.1097/AOG.0000000000004445.
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are collectively referred to as "venous thromboembolic events" (VTE). Despite advances in prophylaxis, diagnosis, and treatment, VTE remains a leading cause of cost, disability, and death in postoperative and hospitalized patients (1, 2). Beyond the acute sequelae of leg pain, edema, and respiratory distress, VTE may result in chronic conditions, including postthrombotic syndrome (3), venous insufficiency, and pulmonary hypertension. This Practice Bulletin has been revised to reflect updated literature on the prevention of VTE in patients undergoing gynecologic surgery and the current surgical thromboprophylaxis guidelines from the American College of Chest Physicians (4). Discussion of gynecologic surgery and chronic antithrombotic therapy is beyond the scope of this document.
深静脉血栓形成(DVT)和肺栓塞(PE)统称为“静脉血栓栓塞事件”(VTE)。尽管在预防、诊断和治疗方面取得了进展,但VTE仍然是术后和住院患者成本、残疾和死亡的主要原因(1,2)。除了腿部疼痛、水肿和呼吸窘迫等急性后遗症外,VTE还可能导致慢性疾病,包括血栓形成后综合征(3)、静脉功能不全和肺动脉高压。本实践公告已进行修订,以反映有关妇科手术患者VTE预防的最新文献以及美国胸科医师学会的现行手术血栓预防指南(4)。妇科手术和慢性抗血栓治疗的讨论不在本文件范围内。